The developer behind Clayton's historic 7 UP building redevelopment faced unexpected challenges, leading to a dramatic shift ...

Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data from its Phase 2 clinical ...